AGP Picks
View all

Hottest science and technology news from New York

Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on May 17, 2026

SpeechTrans Founder Launches GalaxyTranslate Ultimate — Real-Time AI Phone Call Translation for iPhone
New York’s Climate Disclosure Push Is Increasing Pressure on Financial Institutions and Multistate Corporates
The US and UK Are Expanding Virtual Power Plant Markets Faster Than Operators Can Coordinate Them
CADChum Launches High-Speed CAD-to-3D Conversion for Real-Time Workflows
Crypto News Today: AlphaPepe Presale Raises $1.25M While Solana Price Prediction Targets $450
AVITA Medical to Host Investor Webinar Briefing
Life360 Board of Directors Authorizes Up to $225 Million Multi-Year Share Repurchase Program to Offset Stock-Based Compensation Dilution
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
MZTI Investors Have Opportunity to Join The Marzetti Company Fraud Investigation with the Schall Law Firm
LiveRamp Announces Fourth Quarter and Fiscal Year 2026 Results
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Power Solutions International, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Concorde International Group, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
HeroHire Launches Autonomous AI Recruiter to Fix Hiring for the 99%
ApexQuant Announces Launch of Trading Technology Company Focused on Institutional-Style Trading Software for Private Market Participants
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
NANOBIOTIX ANNONCE LA PRÉSENTATION DE DONNÉES DE LA PREMIÉRE PARTIE DE L’ÉTUDE CLINIQUE RANDOMISÉE DE PHASE 2 EVALUANT JNJ-1900 (NBTXR3) DANS LES CANCERS DU POUMON DE STADE 3 INOPÉRABLE

Share us

on your social networks:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.